nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—RET—autonomic nervous system—migraine	0.00801	0.0191	CbGeAlD
Ruxolitinib—Haemorrhage intracranial—Gabapentin—migraine	0.00743	0.0359	CcSEcCtD
Ruxolitinib—Contusion—Verapamil—migraine	0.00595	0.0287	CcSEcCtD
Ruxolitinib—CAMK2G—nerve—migraine	0.0053	0.0127	CbGeAlD
Ruxolitinib—MAP3K3—peripheral nervous system—migraine	0.00527	0.0126	CbGeAlD
Ruxolitinib—LRRK2—nerve—migraine	0.00525	0.0125	CbGeAlD
Ruxolitinib—DCLK3—trigeminal ganglion—migraine	0.00509	0.0121	CbGeAlD
Ruxolitinib—RPS6KA6—brainstem—migraine	0.00475	0.0113	CbGeAlD
Ruxolitinib—BMPR2—blood vessel—migraine	0.00465	0.0111	CbGeAlD
Ruxolitinib—PLK3—trigeminal ganglion—migraine	0.00448	0.0107	CbGeAlD
Ruxolitinib—PRKG2—cardiovascular system—migraine	0.00432	0.0103	CbGeAlD
Ruxolitinib—Contusion—Valproic Acid—migraine	0.00422	0.0203	CcSEcCtD
Ruxolitinib—CAMK1—trigeminal ganglion—migraine	0.00419	0.01	CbGeAlD
Ruxolitinib—Pancytopenia—Amitriptyline—migraine	0.00413	0.0199	CcSEcCtD
Ruxolitinib—Herpes zoster—Gabapentin—migraine	0.00405	0.0195	CcSEcCtD
Ruxolitinib—JAK1—neck—migraine	0.00398	0.0095	CbGeAlD
Ruxolitinib—Weight increased—Amitriptyline—migraine	0.00396	0.0191	CcSEcCtD
Ruxolitinib—RPS6KA6—cardiovascular system—migraine	0.00387	0.00925	CbGeAlD
Ruxolitinib—GRK7—head—migraine	0.00386	0.00922	CbGeAlD
Ruxolitinib—Bone pain—Valproic Acid—migraine	0.00384	0.0185	CcSEcCtD
Ruxolitinib—PLK1—Terbinafine—Propranolol—migraine	0.00384	0.507	CbGdCrCtD
Ruxolitinib—PLK1—Thiothixene—Amitriptyline—migraine	0.00373	0.493	CbGdCrCtD
Ruxolitinib—ANKK1—head—migraine	0.00353	0.00843	CbGeAlD
Ruxolitinib—Contusion—Gabapentin—migraine	0.0035	0.0169	CcSEcCtD
Ruxolitinib—DCLK1—trigeminal ganglion—migraine	0.00344	0.0082	CbGeAlD
Ruxolitinib—JAK1—trigeminal ganglion—migraine	0.00344	0.0082	CbGeAlD
Ruxolitinib—CAMK1D—trigeminal ganglion—migraine	0.00335	0.00801	CbGeAlD
Ruxolitinib—ANKK1—nervous system—migraine	0.00335	0.00799	CbGeAlD
Ruxolitinib—JAK2—blood vessel—migraine	0.00335	0.00799	CbGeAlD
Ruxolitinib—Neutropenia—Propranolol—migraine	0.00331	0.016	CcSEcCtD
Ruxolitinib—DAPK2—trigeminal ganglion—migraine	0.00328	0.00782	CbGeAlD
Ruxolitinib—PLK3—cardiovascular system—migraine	0.00323	0.00772	CbGeAlD
Ruxolitinib—Hypercholesterolaemia—Gabapentin—migraine	0.00322	0.0156	CcSEcCtD
Ruxolitinib—Bone pain—Gabapentin—migraine	0.00318	0.0154	CcSEcCtD
Ruxolitinib—Infestation NOS—Propranolol—migraine	0.00316	0.0152	CcSEcCtD
Ruxolitinib—Infestation—Propranolol—migraine	0.00316	0.0152	CcSEcCtD
Ruxolitinib—DAPK3—trigeminal ganglion—migraine	0.00308	0.00736	CbGeAlD
Ruxolitinib—CLK2—trigeminal ganglion—migraine	0.00305	0.00729	CbGeAlD
Ruxolitinib—BMP2K—neck—migraine	0.00298	0.00711	CbGeAlD
Ruxolitinib—PHKG2—brainstem—migraine	0.00295	0.00704	CbGeAlD
Ruxolitinib—PRKG2—head—migraine	0.00293	0.00698	CbGeAlD
Ruxolitinib—HIPK2—brainstem—migraine	0.00284	0.00678	CbGeAlD
Ruxolitinib—GRK1—head—migraine	0.00279	0.00666	CbGeAlD
Ruxolitinib—PRKG2—nervous system—migraine	0.00277	0.00662	CbGeAlD
Ruxolitinib—NUAK2—trigeminal ganglion—migraine	0.00275	0.00656	CbGeAlD
Ruxolitinib—PRKCE—head—migraine	0.00273	0.00652	CbGeAlD
Ruxolitinib—Bone pain—Topiramate—migraine	0.00268	0.0129	CcSEcCtD
Ruxolitinib—PRKG2—central nervous system—migraine	0.00267	0.00637	CbGeAlD
Ruxolitinib—GRK1—nervous system—migraine	0.00265	0.00632	CbGeAlD
Ruxolitinib—MAST1—head—migraine	0.00262	0.00626	CbGeAlD
Ruxolitinib—RPS6KA6—head—migraine	0.00262	0.00626	CbGeAlD
Ruxolitinib—PLK1—head—migraine	0.00262	0.00626	CbGeAlD
Ruxolitinib—PRKCE—nervous system—migraine	0.00259	0.00618	CbGeAlD
Ruxolitinib—BMP2K—trigeminal ganglion—migraine	0.00257	0.00614	CbGeAlD
Ruxolitinib—DYRK1A—brainstem—migraine	0.00255	0.0061	CbGeAlD
Ruxolitinib—LRRK2—trigeminal ganglion—migraine	0.00255	0.00609	CbGeAlD
Ruxolitinib—GRK1—central nervous system—migraine	0.00255	0.00608	CbGeAlD
Ruxolitinib—BMPR2—brainstem—migraine	0.00254	0.00607	CbGeAlD
Ruxolitinib—RET—neck—migraine	0.00253	0.00605	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—migraine	0.00249	0.00595	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—migraine	0.00249	0.00594	CbGeAlD
Ruxolitinib—PLK1—nervous system—migraine	0.00249	0.00594	CbGeAlD
Ruxolitinib—MAST1—nervous system—migraine	0.00249	0.00594	CbGeAlD
Ruxolitinib—DCLK3—head—migraine	0.00249	0.00594	CbGeAlD
Ruxolitinib—JAK1—cardiovascular system—migraine	0.00248	0.00592	CbGeAlD
Ruxolitinib—PRKCE—cerebellum—migraine	0.00244	0.00582	CbGeAlD
Ruxolitinib—Thrombocytopenia—Amitriptyline—migraine	0.00242	0.0117	CcSEcCtD
Ruxolitinib—RPS6KA6—central nervous system—migraine	0.00239	0.00572	CbGeAlD
Ruxolitinib—PLK1—central nervous system—migraine	0.00239	0.00572	CbGeAlD
Ruxolitinib—MAST1—central nervous system—migraine	0.00239	0.00572	CbGeAlD
Ruxolitinib—DCLK3—nervous system—migraine	0.00236	0.00563	CbGeAlD
Ruxolitinib—Alanine aminotransferase increased—Valproic Acid—migraine	0.00236	0.0114	CcSEcCtD
Ruxolitinib—RPS6KA6—cerebellum—migraine	0.00234	0.00559	CbGeAlD
Ruxolitinib—MAST1—cerebellum—migraine	0.00234	0.00559	CbGeAlD
Ruxolitinib—HIPK2—cardiovascular system—migraine	0.00232	0.00553	CbGeAlD
Ruxolitinib—MAP3K7—trigeminal ganglion—migraine	0.00231	0.00552	CbGeAlD
Ruxolitinib—CAMK2G—brainstem—migraine	0.00228	0.00543	CbGeAlD
Ruxolitinib—TYK2—trigeminal ganglion—migraine	0.00227	0.00542	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—migraine	0.00227	0.00542	CbGeAlD
Ruxolitinib—LRRK2—brainstem—migraine	0.00226	0.00538	CbGeAlD
Ruxolitinib—MKNK2—trigeminal ganglion—migraine	0.00224	0.00535	CbGeAlD
Ruxolitinib—DAPK3—cardiovascular system—migraine	0.00223	0.00531	CbGeAlD
Ruxolitinib—Pancytopenia—Valproic Acid—migraine	0.00219	0.0106	CcSEcCtD
Ruxolitinib—PLK3—head—migraine	0.00219	0.00523	CbGeAlD
Ruxolitinib—RET—trigeminal ganglion—migraine	0.00219	0.00522	CbGeAlD
Ruxolitinib—Neutropenia—Valproic Acid—migraine	0.00216	0.0104	CcSEcCtD
Ruxolitinib—ROCK1—cardiovascular system—migraine	0.00214	0.0051	CbGeAlD
Ruxolitinib—Fatigue—Amitriptyline—migraine	0.00213	0.0103	CcSEcCtD
Ruxolitinib—PRKG2—brain—migraine	0.00212	0.00506	CbGeAlD
Ruxolitinib—LTK—head—migraine	0.00211	0.00505	CbGeAlD
Ruxolitinib—Weight increased—Valproic Acid—migraine	0.0021	0.0101	CcSEcCtD
Ruxolitinib—Weight decreased—Valproic Acid—migraine	0.00209	0.0101	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00209	0.0101	CcSEcCtD
Ruxolitinib—DYRK1A—cardiovascular system—migraine	0.00208	0.00498	CbGeAlD
Ruxolitinib—PLK3—nervous system—migraine	0.00208	0.00496	CbGeAlD
Ruxolitinib—BMPR2—cardiovascular system—migraine	0.00208	0.00496	CbGeAlD
Ruxolitinib—JAK2—trigeminal ganglion—migraine	0.00207	0.00493	CbGeAlD
Ruxolitinib—CAMK1—head—migraine	0.00205	0.00489	CbGeAlD
Ruxolitinib—GRK1—brain—migraine	0.00202	0.00483	CbGeAlD
Ruxolitinib—Urinary tract infection—Valproic Acid—migraine	0.002	0.00965	CcSEcCtD
Ruxolitinib—Infection—Propranolol—migraine	0.002	0.00965	CcSEcCtD
Ruxolitinib—PLK3—central nervous system—migraine	0.002	0.00477	CbGeAlD
Ruxolitinib—MAP3K3—trigeminal ganglion—migraine	0.00199	0.00476	CbGeAlD
Ruxolitinib—MARK2—head—migraine	0.00199	0.00475	CbGeAlD
Ruxolitinib—PRKCE—brain—migraine	0.00198	0.00472	CbGeAlD
Ruxolitinib—Nervous system disorder—Propranolol—migraine	0.00197	0.00952	CcSEcCtD
Ruxolitinib—Skin disorder—Propranolol—migraine	0.00195	0.00943	CcSEcCtD
Ruxolitinib—Body temperature increased—Amitriptyline—migraine	0.00195	0.00943	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Valproic Acid—migraine	0.00195	0.00939	CcSEcCtD
Ruxolitinib—CAMK1—nervous system—migraine	0.00194	0.00464	CbGeAlD
Ruxolitinib—Epistaxis—Valproic Acid—migraine	0.00194	0.00937	CcSEcCtD
Ruxolitinib—RPS6KA6—brain—migraine	0.0019	0.00454	CbGeAlD
Ruxolitinib—PLK1—brain—migraine	0.0019	0.00454	CbGeAlD
Ruxolitinib—MAST1—brain—migraine	0.0019	0.00454	CbGeAlD
Ruxolitinib—MARK2—nervous system—migraine	0.00189	0.0045	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—migraine	0.00187	0.00446	CbGeAlD
Ruxolitinib—Weight decreased—Timolol—migraine	0.00186	0.00897	CcSEcCtD
Ruxolitinib—CAMK2G—cardiovascular system—migraine	0.00186	0.00443	CbGeAlD
Ruxolitinib—Haemoglobin—Valproic Acid—migraine	0.00186	0.00896	CcSEcCtD
Ruxolitinib—Haemorrhage—Valproic Acid—migraine	0.00185	0.00891	CcSEcCtD
Ruxolitinib—Infection—Verapamil—migraine	0.00184	0.00887	CcSEcCtD
Ruxolitinib—CAMK1—cerebellum—migraine	0.00183	0.00436	CbGeAlD
Ruxolitinib—TAOK3—trigeminal ganglion—migraine	0.00182	0.00434	CbGeAlD
Ruxolitinib—MARK2—central nervous system—migraine	0.00181	0.00433	CbGeAlD
Ruxolitinib—DCLK3—brain—migraine	0.0018	0.0043	CbGeAlD
Ruxolitinib—MARK2—cerebellum—migraine	0.00177	0.00424	CbGeAlD
Ruxolitinib—Asthenia—Amitriptyline—migraine	0.00177	0.00856	CcSEcCtD
Ruxolitinib—Pruritus—Amitriptyline—migraine	0.00175	0.00844	CcSEcCtD
Ruxolitinib—Weight increased—Gabapentin—migraine	0.00174	0.0084	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Propranolol—migraine	0.00174	0.00838	CcSEcCtD
Ruxolitinib—Fatigue—Propranolol—migraine	0.00174	0.00837	CcSEcCtD
Ruxolitinib—Weight decreased—Gabapentin—migraine	0.00173	0.00835	CcSEcCtD
Ruxolitinib—Epistaxis—Timolol—migraine	0.00173	0.00834	CcSEcCtD
Ruxolitinib—Infestation—Gabapentin—migraine	0.00171	0.00823	CcSEcCtD
Ruxolitinib—Infestation NOS—Gabapentin—migraine	0.00171	0.00823	CcSEcCtD
Ruxolitinib—JAK3—head—migraine	0.00169	0.00404	CbGeAlD
Ruxolitinib—DCLK1—head—migraine	0.00168	0.00401	CbGeAlD
Ruxolitinib—JAK1—head—migraine	0.00168	0.00401	CbGeAlD
Ruxolitinib—Urinary tract infection—Gabapentin—migraine	0.00166	0.008	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Topiramate—migraine	0.00164	0.00793	CcSEcCtD
Ruxolitinib—TAOK2—cerebellum—migraine	0.00164	0.00392	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—migraine	0.00164	0.00392	CbGeAlD
Ruxolitinib—CAMK1D—head—migraine	0.00164	0.00392	CbGeAlD
Ruxolitinib—Dizziness—Amitriptyline—migraine	0.00163	0.00789	CcSEcCtD
Ruxolitinib—PHKG2—head—migraine	0.00163	0.00389	CbGeAlD
Ruxolitinib—Haematuria—Gabapentin—migraine	0.00163	0.00785	CcSEcCtD
Ruxolitinib—MKNK2—cardiovascular system—migraine	0.00162	0.00387	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Gabapentin—migraine	0.00161	0.00778	CcSEcCtD
Ruxolitinib—Epistaxis—Gabapentin—migraine	0.00161	0.00776	CcSEcCtD
Ruxolitinib—Malnutrition—Valproic Acid—migraine	0.00161	0.00776	CcSEcCtD
Ruxolitinib—TAOK3—brainstem—migraine	0.00161	0.00384	CbGeAlD
Ruxolitinib—JAK3—nervous system—migraine	0.0016	0.00383	CbGeAlD
Ruxolitinib—Fatigue—Verapamil—migraine	0.0016	0.0077	CcSEcCtD
Ruxolitinib—DCLK1—nervous system—migraine	0.00159	0.0038	CbGeAlD
Ruxolitinib—JAK1—nervous system—migraine	0.00159	0.0038	CbGeAlD
Ruxolitinib—Body temperature increased—Propranolol—migraine	0.00159	0.00768	CcSEcCtD
Ruxolitinib—PLK3—brain—migraine	0.00159	0.00379	CbGeAlD
Ruxolitinib—Flatulence—Valproic Acid—migraine	0.00158	0.00765	CcSEcCtD
Ruxolitinib—STK16—head—migraine	0.00158	0.00376	CbGeAlD
Ruxolitinib—HIPK2—head—migraine	0.00157	0.00374	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—migraine	0.00155	0.00371	CbGeAlD
Ruxolitinib—Headache—Amitriptyline—migraine	0.00155	0.00747	CcSEcCtD
Ruxolitinib—PHKG2—nervous system—migraine	0.00155	0.00369	CbGeAlD
Ruxolitinib—JAK3—central nervous system—migraine	0.00154	0.00368	CbGeAlD
Ruxolitinib—MAP3K19—head—migraine	0.00154	0.00367	CbGeAlD
Ruxolitinib—JAK1—central nervous system—migraine	0.00153	0.00366	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—migraine	0.00153	0.00366	CbGeAlD
Ruxolitinib—LTK—brain—migraine	0.00153	0.00366	CbGeAlD
Ruxolitinib—Haemorrhage—Gabapentin—migraine	0.00153	0.00739	CcSEcCtD
Ruxolitinib—Pancytopenia—Topiramate—migraine	0.00153	0.00738	CcSEcCtD
Ruxolitinib—JAK3—cerebellum—migraine	0.00151	0.0036	CbGeAlD
Ruxolitinib—DAPK3—head—migraine	0.00151	0.0036	CbGeAlD
Ruxolitinib—Neutropenia—Topiramate—migraine	0.00151	0.00726	CcSEcCtD
Ruxolitinib—JAK1—cerebellum—migraine	0.0015	0.00358	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—migraine	0.0015	0.00358	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—migraine	0.0015	0.00357	CbGeAlD
Ruxolitinib—STK16—nervous system—migraine	0.00149	0.00357	CbGeAlD
Ruxolitinib—CLK2—head—migraine	0.00149	0.00356	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—migraine	0.00149	0.00356	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—migraine	0.00149	0.00355	CbGeAlD
Ruxolitinib—HIPK2—nervous system—migraine	0.00149	0.00355	CbGeAlD
Ruxolitinib—Anaemia—Valproic Acid—migraine	0.00149	0.00717	CcSEcCtD
Ruxolitinib—CAMK1—brain—migraine	0.00148	0.00354	CbGeAlD
Ruxolitinib—Weight increased—Topiramate—migraine	0.00147	0.00707	CcSEcCtD
Ruxolitinib—CAMK1D—cerebellum—migraine	0.00146	0.00349	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—migraine	0.00146	0.00348	CbGeAlD
Ruxolitinib—Weight decreased—Topiramate—migraine	0.00146	0.00703	CcSEcCtD
Ruxolitinib—PHKG2—cerebellum—migraine	0.00145	0.00347	CbGeAlD
Ruxolitinib—ROCK1—head—migraine	0.00145	0.00345	CbGeAlD
Ruxolitinib—Asthenia—Propranolol—migraine	0.00144	0.00697	CcSEcCtD
Ruxolitinib—MARK2—brain—migraine	0.00144	0.00344	CbGeAlD
Ruxolitinib—STK16—central nervous system—migraine	0.00144	0.00344	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—migraine	0.00144	0.00343	CbGeAlD
Ruxolitinib—Infestation—Topiramate—migraine	0.00144	0.00693	CcSEcCtD
Ruxolitinib—Infestation NOS—Topiramate—migraine	0.00144	0.00693	CcSEcCtD
Ruxolitinib—Malnutrition—Timolol—migraine	0.00143	0.00691	CcSEcCtD
Ruxolitinib—HIPK2—central nervous system—migraine	0.00143	0.00342	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—migraine	0.00143	0.00341	CbGeAlD
Ruxolitinib—DAPK3—nervous system—migraine	0.00143	0.00341	CbGeAlD
Ruxolitinib—CLK2—nervous system—migraine	0.00142	0.00338	CbGeAlD
Ruxolitinib—DYRK1A—head—migraine	0.00141	0.00337	CbGeAlD
Ruxolitinib—STK16—cerebellum—migraine	0.00141	0.00336	CbGeAlD
Ruxolitinib—BMPR2—head—migraine	0.00141	0.00336	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—migraine	0.0014	0.00335	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—migraine	0.0014	0.00334	CbGeAlD
Ruxolitinib—Urinary tract infection—Topiramate—migraine	0.0014	0.00673	CcSEcCtD
Ruxolitinib—DAPK3—central nervous system—migraine	0.00138	0.00328	CbGeAlD
Ruxolitinib—ROCK1—nervous system—migraine	0.00137	0.00327	CbGeAlD
Ruxolitinib—Haematuria—Topiramate—migraine	0.00137	0.0066	CcSEcCtD
Ruxolitinib—CLK2—central nervous system—migraine	0.00136	0.00325	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00136	0.00656	CcSEcCtD
Ruxolitinib—Epistaxis—Topiramate—migraine	0.00135	0.00653	CcSEcCtD
Ruxolitinib—DAPK3—cerebellum—migraine	0.00134	0.00321	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—migraine	0.00134	0.00319	CbGeAlD
Ruxolitinib—Malnutrition—Gabapentin—migraine	0.00133	0.00643	CcSEcCtD
Ruxolitinib—TAOK2—brain—migraine	0.00133	0.00318	CbGeAlD
Ruxolitinib—BMPR2—nervous system—migraine	0.00133	0.00318	CbGeAlD
Ruxolitinib—CLK2—cerebellum—migraine	0.00133	0.00318	CbGeAlD
Ruxolitinib—Dizziness—Propranolol—migraine	0.00133	0.00642	CcSEcCtD
Ruxolitinib—Asthenia—Verapamil—migraine	0.00133	0.00641	CcSEcCtD
Ruxolitinib—ROCK1—central nervous system—migraine	0.00132	0.00315	CbGeAlD
Ruxolitinib—Flatulence—Gabapentin—migraine	0.00131	0.00634	CcSEcCtD
Ruxolitinib—TAOK3—cardiovascular system—migraine	0.00131	0.00313	CbGeAlD
Ruxolitinib—Pruritus—Verapamil—migraine	0.00131	0.00632	CcSEcCtD
Ruxolitinib—Infection—Valproic Acid—migraine	0.0013	0.00629	CcSEcCtD
Ruxolitinib—Haemoglobin—Topiramate—migraine	0.0013	0.00625	CcSEcCtD
Ruxolitinib—Haemorrhage—Topiramate—migraine	0.00129	0.00622	CcSEcCtD
Ruxolitinib—DYRK1A—central nervous system—migraine	0.00129	0.00308	CbGeAlD
Ruxolitinib—Nervous system disorder—Valproic Acid—migraine	0.00129	0.00621	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Valproic Acid—migraine	0.00129	0.0062	CcSEcCtD
Ruxolitinib—BMPR2—central nervous system—migraine	0.00128	0.00306	CbGeAlD
Ruxolitinib—Skin disorder—Valproic Acid—migraine	0.00128	0.00615	CcSEcCtD
Ruxolitinib—DYRK1A—cerebellum—migraine	0.00126	0.00301	CbGeAlD
Ruxolitinib—BMP2K—head—migraine	0.00126	0.003	CbGeAlD
Ruxolitinib—CAMK2G—head—migraine	0.00126	0.003	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—migraine	0.00125	0.00299	CbGeAlD
Ruxolitinib—LRRK2—head—migraine	0.00125	0.00298	CbGeAlD
Ruxolitinib—Anaemia—Gabapentin—migraine	0.00123	0.00595	CcSEcCtD
Ruxolitinib—JAK3—brain—migraine	0.00123	0.00293	CbGeAlD
Ruxolitinib—Dizziness—Verapamil—migraine	0.00122	0.00591	CcSEcCtD
Ruxolitinib—JAK1—brain—migraine	0.00122	0.00291	CbGeAlD
Ruxolitinib—DCLK1—brain—migraine	0.00122	0.00291	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00121	0.00584	CcSEcCtD
Ruxolitinib—PLK4—brain—migraine	0.00121	0.00289	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—migraine	0.0012	0.00286	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—migraine	0.00119	0.00285	CbGeAlD
Ruxolitinib—BMP2K—nervous system—migraine	0.00119	0.00285	CbGeAlD
Ruxolitinib—CAMK1D—brain—migraine	0.00119	0.00284	CbGeAlD
Ruxolitinib—LRRK2—nervous system—migraine	0.00118	0.00282	CbGeAlD
Ruxolitinib—PHKG2—brain—migraine	0.00118	0.00282	CbGeAlD
Ruxolitinib—DAPK2—brain—migraine	0.00116	0.00277	CbGeAlD
Ruxolitinib—Infection—Timolol—migraine	0.00116	0.0056	CcSEcCtD
Ruxolitinib—Headache—Verapamil—migraine	0.00116	0.0056	CcSEcCtD
Ruxolitinib—BMP2K—central nervous system—migraine	0.00115	0.00274	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—migraine	0.00115	0.00274	CbGeAlD
Ruxolitinib—Nervous system disorder—Timolol—migraine	0.00115	0.00553	CcSEcCtD
Ruxolitinib—STK16—brain—migraine	0.00114	0.00273	CbGeAlD
Ruxolitinib—MAP3K2—head—migraine	0.00114	0.00273	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—migraine	0.00114	0.00272	CbGeAlD
Ruxolitinib—HIPK2—brain—migraine	0.00114	0.00271	CbGeAlD
Ruxolitinib—Skin disorder—Timolol—migraine	0.00114	0.00548	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Valproic Acid—migraine	0.00113	0.00547	CcSEcCtD
Ruxolitinib—Fatigue—Valproic Acid—migraine	0.00113	0.00546	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00113	0.00544	CcSEcCtD
Ruxolitinib—CAMK2G—cerebellum—migraine	0.00112	0.00268	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—migraine	0.00112	0.00268	CbGeAlD
Ruxolitinib—Malnutrition—Topiramate—migraine	0.00112	0.00541	CcSEcCtD
Ruxolitinib—MAP3K19—brain—migraine	0.00111	0.00266	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—migraine	0.00111	0.00265	CbGeAlD
Ruxolitinib—TYK2—head—migraine	0.00111	0.00265	CbGeAlD
Ruxolitinib—Flatulence—Topiramate—migraine	0.00111	0.00533	CcSEcCtD
Ruxolitinib—MKNK2—head—migraine	0.0011	0.00262	CbGeAlD
Ruxolitinib—DAPK3—brain—migraine	0.00109	0.00261	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—migraine	0.00108	0.00259	CbGeAlD
Ruxolitinib—CLK2—brain—migraine	0.00108	0.00258	CbGeAlD
Ruxolitinib—Infection—Gabapentin—migraine	0.00108	0.00522	CcSEcCtD
Ruxolitinib—RET—head—migraine	0.00107	0.00255	CbGeAlD
Ruxolitinib—Nervous system disorder—Gabapentin—migraine	0.00107	0.00515	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Gabapentin—migraine	0.00107	0.00514	CcSEcCtD
Ruxolitinib—Skin disorder—Gabapentin—migraine	0.00106	0.0051	CcSEcCtD
Ruxolitinib—TYK2—nervous system—migraine	0.00105	0.00251	CbGeAlD
Ruxolitinib—ROCK1—brain—migraine	0.00105	0.0025	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—migraine	0.00104	0.00249	CbGeAlD
Ruxolitinib—MKNK2—nervous system—migraine	0.00104	0.00248	CbGeAlD
Ruxolitinib—Body temperature increased—Valproic Acid—migraine	0.00104	0.00501	CcSEcCtD
Ruxolitinib—Anaemia—Topiramate—migraine	0.00104	0.005	CcSEcCtD
Ruxolitinib—DYRK1A—brain—migraine	0.00102	0.00244	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—migraine	0.00102	0.00243	CbGeAlD
Ruxolitinib—BMPR2—brain—migraine	0.00102	0.00243	CbGeAlD
Ruxolitinib—TYK2—central nervous system—migraine	0.00101	0.00242	CbGeAlD
Ruxolitinib—RET—nervous system—migraine	0.00101	0.00242	CbGeAlD
Ruxolitinib—JAK2—head—migraine	0.00101	0.00241	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—migraine	0.00101	0.00241	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Timolol—migraine	0.00101	0.00487	CcSEcCtD
Ruxolitinib—Fatigue—Timolol—migraine	0.00101	0.00486	CcSEcCtD
Ruxolitinib—MKNK2—central nervous system—migraine	0.001	0.00239	CbGeAlD
Ruxolitinib—TYK2—cerebellum—migraine	0.000991	0.00237	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—migraine	0.000978	0.00234	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—migraine	0.000978	0.00234	CbGeAlD
Ruxolitinib—RET—central nervous system—migraine	0.000976	0.00233	CbGeAlD
Ruxolitinib—MAP3K3—head—migraine	0.000974	0.00233	CbGeAlD
Ruxolitinib—NUAK2—brain—migraine	0.000973	0.00232	CbGeAlD
Ruxolitinib—JAK2—nervous system—migraine	0.000958	0.00229	CbGeAlD
Ruxolitinib—RET—cerebellum—migraine	0.000954	0.00228	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000948	0.00458	CcSEcCtD
Ruxolitinib—Asthenia—Valproic Acid—migraine	0.000942	0.00454	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Gabapentin—migraine	0.00094	0.00453	CcSEcCtD
Ruxolitinib—Fatigue—Gabapentin—migraine	0.000938	0.00453	CcSEcCtD
Ruxolitinib—Pruritus—Valproic Acid—migraine	0.000929	0.00448	CcSEcCtD
Ruxolitinib—Body temperature increased—Timolol—migraine	0.000924	0.00446	CcSEcCtD
Ruxolitinib—MAP3K3—nervous system—migraine	0.000924	0.00221	CbGeAlD
Ruxolitinib—JAK2—central nervous system—migraine	0.000923	0.0022	CbGeAlD
Ruxolitinib—CAMK2G—brain—migraine	0.000911	0.00218	CbGeAlD
Ruxolitinib—BMP2K—brain—migraine	0.000911	0.00218	CbGeAlD
Ruxolitinib—Infection—Topiramate—migraine	0.00091	0.00439	CcSEcCtD
Ruxolitinib—LRRK2—brain—migraine	0.000903	0.00216	CbGeAlD
Ruxolitinib—JAK2—cerebellum—migraine	0.000902	0.00215	CbGeAlD
Ruxolitinib—Nervous system disorder—Topiramate—migraine	0.000898	0.00433	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Topiramate—migraine	0.000896	0.00432	CcSEcCtD
Ruxolitinib—Skin disorder—Topiramate—migraine	0.000889	0.00429	CcSEcCtD
Ruxolitinib—MAP3K3—central nervous system—migraine	0.000889	0.00212	CbGeAlD
Ruxolitinib—TAOK3—head—migraine	0.000888	0.00212	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—migraine	0.000869	0.00207	CbGeAlD
Ruxolitinib—Dizziness—Valproic Acid—migraine	0.000868	0.00419	CcSEcCtD
Ruxolitinib—Body temperature increased—Gabapentin—migraine	0.00086	0.00415	CcSEcCtD
Ruxolitinib—TAOK3—nervous system—migraine	0.000842	0.00201	CbGeAlD
Ruxolitinib—Asthenia—Timolol—migraine	0.000838	0.00404	CcSEcCtD
Ruxolitinib—MAP3K2—brain—migraine	0.000828	0.00198	CbGeAlD
Ruxolitinib—Pruritus—Timolol—migraine	0.000827	0.00399	CcSEcCtD
Ruxolitinib—Headache—Valproic Acid—migraine	0.000822	0.00397	CcSEcCtD
Ruxolitinib—MAP3K7—brain—migraine	0.00082	0.00196	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—migraine	0.000811	0.00194	CbGeAlD
Ruxolitinib—TYK2—brain—migraine	0.000805	0.00192	CbGeAlD
Ruxolitinib—IRAK1—brain—migraine	0.000795	0.0019	CbGeAlD
Ruxolitinib—MKNK2—brain—migraine	0.000795	0.0019	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—migraine	0.000792	0.00189	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Topiramate—migraine	0.00079	0.00381	CcSEcCtD
Ruxolitinib—Fatigue—Topiramate—migraine	0.000789	0.00381	CcSEcCtD
Ruxolitinib—Asthenia—Gabapentin—migraine	0.000781	0.00377	CcSEcCtD
Ruxolitinib—RET—brain—migraine	0.000775	0.00185	CbGeAlD
Ruxolitinib—Dizziness—Timolol—migraine	0.000773	0.00373	CcSEcCtD
Ruxolitinib—Pruritus—Gabapentin—migraine	0.00077	0.00371	CcSEcCtD
Ruxolitinib—JAK2—brain—migraine	0.000732	0.00175	CbGeAlD
Ruxolitinib—Headache—Timolol—migraine	0.000732	0.00353	CcSEcCtD
Ruxolitinib—Body temperature increased—Topiramate—migraine	0.000724	0.00349	CcSEcCtD
Ruxolitinib—Dizziness—Gabapentin—migraine	0.00072	0.00347	CcSEcCtD
Ruxolitinib—MAP3K3—brain—migraine	0.000706	0.00169	CbGeAlD
Ruxolitinib—Headache—Gabapentin—migraine	0.000682	0.00329	CcSEcCtD
Ruxolitinib—Asthenia—Topiramate—migraine	0.000657	0.00317	CcSEcCtD
Ruxolitinib—Pruritus—Topiramate—migraine	0.000648	0.00312	CcSEcCtD
Ruxolitinib—TAOK3—brain—migraine	0.000644	0.00154	CbGeAlD
Ruxolitinib—Dizziness—Topiramate—migraine	0.000605	0.00292	CcSEcCtD
Ruxolitinib—Headache—Topiramate—migraine	0.000574	0.00277	CcSEcCtD
Ruxolitinib—CYP3A4—nervous system—migraine	0.000256	0.000611	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—migraine	0.000246	0.000588	CbGeAlD
Ruxolitinib—PHKG2—Disease—MTHFR—migraine	0.000161	0.000439	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR1D—migraine	0.00016	0.000438	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CALCA—migraine	0.00016	0.000436	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CALCA—migraine	0.00016	0.000436	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—HTR2C—migraine	0.000159	0.000434	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—MTHFR—migraine	0.000158	0.000433	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HTR1B—migraine	0.000158	0.000431	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—EDNRA—migraine	0.000157	0.000429	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RAMP1—migraine	0.000156	0.000427	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CALCRL—migraine	0.000156	0.000427	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—FOS—migraine	0.000156	0.000425	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HTR1B—migraine	0.000155	0.000424	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—EDNRA—migraine	0.000155	0.000422	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR1D—migraine	0.000154	0.00042	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TGFBR2—migraine	0.000153	0.000419	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HTR1A—migraine	0.000152	0.000415	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RAMP1—migraine	0.000152	0.000414	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CALCRL—migraine	0.000152	0.000414	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR1D—migraine	0.000151	0.000413	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—CALCA—migraine	0.000151	0.000413	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—TAC1—migraine	0.00015	0.000408	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—NPS—migraine	0.00015	0.000408	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HTR1A—migraine	0.000149	0.000408	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—HTR7—migraine	0.000149	0.000408	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR2B—migraine	0.000149	0.000407	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—CALCA—migraine	0.000149	0.000406	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—TAC1—migraine	0.000147	0.000402	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—NPS—migraine	0.000147	0.000402	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HTR2C—migraine	0.000147	0.000401	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—LRP1—migraine	0.000146	0.0004	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR1D—migraine	0.000146	0.000398	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HTR2C—migraine	0.000144	0.000394	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000144	0.000394	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2B—migraine	0.000143	0.000391	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—EDNRA—migraine	0.000143	0.00039	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—HTR7—migraine	0.000142	0.000386	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2B—migraine	0.000141	0.000384	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—EDNRA—migraine	0.00014	0.000383	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—HTR7—migraine	0.000139	0.00038	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TGFBR2—migraine	0.000139	0.000379	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CALCA—migraine	0.000137	0.000375	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—HTR2A—migraine	0.000137	0.000373	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000136	0.000371	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2B—migraine	0.000135	0.00037	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CALCA—migraine	0.000135	0.000369	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—MTHFR—migraine	0.000135	0.000368	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOTCH4—migraine	0.000133	0.000363	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—LRP1—migraine	0.000133	0.000362	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—HTR2A—migraine	0.000133	0.000362	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TGFBR2—migraine	0.000129	0.000351	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HTR7—migraine	0.000129	0.000351	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR1B—migraine	0.000128	0.000351	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HTR7—migraine	0.000126	0.000345	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—LRP1—migraine	0.000126	0.000344	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—HTR2A—migraine	0.000125	0.00034	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—HTR2A—migraine	0.000124	0.000338	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—LRP1—migraine	0.000124	0.000338	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR1A—migraine	0.000124	0.000337	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—PGR—migraine	0.000122	0.000332	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NPS—migraine	0.000122	0.000332	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TAC1—migraine	0.000122	0.000332	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR2C—migraine	0.000119	0.000326	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RAMP1—migraine	0.000118	0.000323	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CALCRL—migraine	0.000118	0.000323	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—ESR1—migraine	0.000118	0.000321	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR1D—migraine	0.000117	0.000319	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TNF—migraine	0.000117	0.000318	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR1B—migraine	0.000117	0.000318	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EDNRA—migraine	0.000116	0.000317	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CALCA—migraine	0.000116	0.000316	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—HTR2A—migraine	0.000115	0.000315	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR1D—migraine	0.000114	0.00031	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOTCH3—migraine	0.000113	0.000309	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—FOS—migraine	0.000113	0.000308	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—HTR2A—migraine	0.000113	0.000308	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOTCH4—migraine	0.000112	0.000307	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR1A—migraine	0.000112	0.000306	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CALCA—migraine	0.000112	0.000305	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—ESR1—migraine	0.000111	0.000302	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—TAC1—migraine	0.00011	0.000302	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—NPS—migraine	0.00011	0.000302	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR1D—migraine	0.00011	0.000301	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2B—migraine	0.000109	0.000297	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR1B—migraine	0.000108	0.000296	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR2C—migraine	0.000108	0.000296	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2B—migraine	0.000106	0.000288	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—EDNRA—migraine	0.000105	0.000288	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—HTR2A—migraine	0.000105	0.000286	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR7—migraine	0.000105	0.000285	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—MTHFR—migraine	0.000104	0.000285	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR1A—migraine	0.000104	0.000285	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NPS—migraine	0.000103	0.00028	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TAC1—migraine	0.000103	0.00028	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PGR—migraine	0.000103	0.00028	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2B—migraine	0.000102	0.00028	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CALCA—migraine	0.000101	0.000277	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR2C—migraine	0.000101	0.000275	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—LRP1—migraine	0.000101	0.000275	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—ESR1—migraine	0.0001	0.000273	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—HTR2A—migraine	9.91e-05	0.000271	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EDNRA—migraine	9.8e-05	0.000268	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—HTR2A—migraine	9.75e-05	0.000266	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR1B—migraine	9.72e-05	0.000265	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOTCH4—migraine	9.66e-05	0.000264	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LRP1—migraine	9.58e-05	0.000261	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOTCH3—migraine	9.55e-05	0.000261	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOTCH4—migraine	9.5e-05	0.000259	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR7—migraine	9.49e-05	0.000259	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CALCA—migraine	9.43e-05	0.000258	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR1A—migraine	9.36e-05	0.000256	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFBR2—migraine	9.34e-05	0.000255	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR1B—migraine	9.32e-05	0.000255	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LRP1—migraine	9.3e-05	0.000254	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—TAC1—migraine	9.22e-05	0.000252	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—NPS—migraine	9.22e-05	0.000252	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR1B—migraine	9.17e-05	0.00025	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FOS—migraine	9.06e-05	0.000247	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR2C—migraine	9.04e-05	0.000247	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LRP1—migraine	9.02e-05	0.000246	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFBR2—migraine	9e-05	0.000246	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HTR2A—migraine	9e-05	0.000246	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR1A—migraine	8.97e-05	0.000245	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HTR2A—migraine	8.85e-05	0.000242	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TAC1—migraine	8.84e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PGR—migraine	8.84e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NPS—migraine	8.84e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR1B—migraine	8.83e-05	0.000241	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR1A—migraine	8.83e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR7—migraine	8.82e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—EDNRA—migraine	8.79e-05	0.00024	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NPS—migraine	8.69e-05	0.000237	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TAC1—migraine	8.69e-05	0.000237	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PGR—migraine	8.69e-05	0.000237	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2C—migraine	8.67e-05	0.000237	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1D—migraine	8.61e-05	0.000235	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FOS—migraine	8.59e-05	0.000234	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CALCA—migraine	8.56e-05	0.000234	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2C—migraine	8.52e-05	0.000233	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR1A—migraine	8.5e-05	0.000232	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CALCA—migraine	8.46e-05	0.000231	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EDNRA—migraine	8.43e-05	0.00023	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—NPS—migraine	8.37e-05	0.000229	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TAC1—migraine	8.37e-05	0.000229	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FOS—migraine	8.34e-05	0.000228	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FOS—migraine	8.3e-05	0.000227	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EDNRA—migraine	8.29e-05	0.000226	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOTCH3—migraine	8.22e-05	0.000224	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2C—migraine	8.21e-05	0.000224	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CALCA—migraine	8.12e-05	0.000222	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FOS—migraine	8.11e-05	0.000221	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FOS—migraine	8.09e-05	0.000221	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOTCH3—migraine	8.08e-05	0.000221	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2B—migraine	8e-05	0.000218	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—EDNRA—migraine	7.98e-05	0.000218	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CALCA—migraine	7.98e-05	0.000218	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR7—migraine	7.92e-05	0.000216	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CALCA—migraine	7.69e-05	0.00021	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FOS—migraine	7.65e-05	0.000209	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFBR2—migraine	7.6e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR7—migraine	7.59e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—MTHFR—migraine	7.58e-05	0.000207	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR7—migraine	7.47e-05	0.000204	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOTCH4—migraine	7.35e-05	0.000201	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR2A—migraine	7.32e-05	0.0002	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR7—migraine	7.19e-05	0.000196	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOTCH4—migraine	7.13e-05	0.000195	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR1B—migraine	7.09e-05	0.000194	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LRP1—migraine	7.05e-05	0.000192	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOTCH4—migraine	6.92e-05	0.000189	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFBR2—migraine	6.89e-05	0.000188	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR1B—migraine	6.88e-05	0.000188	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TNF—migraine	6.87e-05	0.000188	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR1A—migraine	6.82e-05	0.000186	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TNF—migraine	6.76e-05	0.000185	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TAC1—migraine	6.72e-05	0.000183	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PGR—migraine	6.72e-05	0.000183	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NPS—migraine	6.72e-05	0.000183	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR1B—migraine	6.68e-05	0.000182	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR2A—migraine	6.64e-05	0.000181	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR1A—migraine	6.62e-05	0.000181	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2C—migraine	6.59e-05	0.00018	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FOS—migraine	6.58e-05	0.00018	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFBR2—migraine	6.54e-05	0.000178	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TAC1—migraine	6.52e-05	0.000178	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NPS—migraine	6.52e-05	0.000178	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PGR—migraine	6.52e-05	0.000178	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—ESR1—migraine	6.5e-05	0.000177	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CALCA—migraine	6.48e-05	0.000177	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFBR2—migraine	6.43e-05	0.000176	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR1A—migraine	6.43e-05	0.000175	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EDNRA—migraine	6.41e-05	0.000175	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2C—migraine	6.4e-05	0.000175	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PGR—migraine	6.33e-05	0.000173	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NPS—migraine	6.33e-05	0.000173	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TAC1—migraine	6.33e-05	0.000173	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FOS—migraine	6.32e-05	0.000173	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOTCH3—migraine	6.25e-05	0.000171	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EDNRA—migraine	6.22e-05	0.00017	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2C—migraine	6.21e-05	0.000169	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR2A—migraine	6.18e-05	0.000169	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CALCA—migraine	6.17e-05	0.000168	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOTCH3—migraine	6.07e-05	0.000166	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EDNRA—migraine	6.04e-05	0.000165	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CALCA—migraine	5.99e-05	0.000164	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOTCH3—migraine	5.88e-05	0.000161	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CALCA—migraine	5.81e-05	0.000159	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR7—migraine	5.77e-05	0.000158	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR7—migraine	5.6e-05	0.000153	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MTHFR—migraine	5.6e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR2A—migraine	5.54e-05	0.000151	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—ESR1—migraine	5.49e-05	0.00015	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR7—migraine	5.44e-05	0.000148	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOTCH4—migraine	5.41e-05	0.000148	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2A—migraine	5.32e-05	0.000145	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2A—migraine	5.23e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFBR2—migraine	5.22e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1B—migraine	5.22e-05	0.000142	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—migraine	5.08e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2A—migraine	5.04e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1A—migraine	5.02e-05	0.000137	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FOS—migraine	5e-05	0.000137	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFBR2—migraine	4.97e-05	0.000136	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PGR—migraine	4.94e-05	0.000135	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NPS—migraine	4.94e-05	0.000135	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TAC1—migraine	4.94e-05	0.000135	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FOS—migraine	4.86e-05	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2C—migraine	4.85e-05	0.000132	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFBR2—migraine	4.83e-05	0.000132	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ESR1—migraine	4.72e-05	0.000129	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EDNRA—migraine	4.72e-05	0.000129	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FOS—migraine	4.71e-05	0.000129	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFBR2—migraine	4.68e-05	0.000128	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ESR1—migraine	4.64e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOTCH3—migraine	4.6e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CALCA—migraine	4.54e-05	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR7—migraine	4.25e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTHFR—migraine	4.24e-05	0.000116	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2A—migraine	4.04e-05	0.00011	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2A—migraine	3.92e-05	0.000107	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—migraine	3.85e-05	0.000105	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2A—migraine	3.81e-05	0.000104	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FOS—migraine	3.68e-05	0.0001	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFBR2—migraine	3.66e-05	9.99e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ESR1—migraine	3.59e-05	9.8e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ESR1—migraine	3.48e-05	9.51e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ESR1—migraine	3.38e-05	9.22e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNA1A—migraine	3.04e-05	8.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2A—migraine	2.97e-05	8.12e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ESR1—migraine	2.64e-05	7.21e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—migraine	1e-05	2.74e-05	CbGpPWpGaD
